Clinical Trial Update: Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating LY2228820 with radiotherapy and temozolomide in newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• LY2228820 (LY2228820)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Adult Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED